Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models

Published:2014-12-12 Issue:2 Volume:14 Page:480-490
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Peng Sheng-Bin,Zhang Xiaoyi,Paul Donald,Kays Lisa M.,Gough Wendy,Stewart Julie,Uhlik Mark T.,Chen Qi,Hui Yu-Hua,Zamek-Gliszczynski Maciej J.,Wijsman John A.,Credille Kelly M.,Yan Liang Zeng

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites;European Journal of Medicinal Chemistry;2024-10

2. CXCR4 as a therapeutic target in acute myeloid leukemia;Leukemia;2024-09-11

3. Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignancies;Expert Opinion on Investigational Drugs;2024-08-08

4. C-X-C motif chemokine ligand 12―C-X-C chemokine receptor type 4 signaling axis in cancer and the development of chemotherapeutic molecules;Tzu Chi Medical Journal;2024-05-27

5. Chemokine systems in oncology: From microenvironment modulation to nanocarrier innovations;International Journal of Biological Macromolecules;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP